https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-revokes-emergency-use-authorization-monoclonal-antibody-bamlanivimab

Originally published by:  fda.gov

Author: staff

Date: 4/16/2021

Categories: Integrative Therapies,Treatment

Comments

0 Comments

Submit a Comment